CJ Biomaterials Expands PHA Offering, Introduces New Semi-Crystalline PHA Biopolymer at NPE 2024
Woburn, Massachusetts--(Newsfile Corp. - May 8, 2024) - CJ Biomaterials, Inc, a division of South Korea-based CJ CheilJedang and a primary producer of polyhydroxyalkanoate (PHA) biopolymers, introduced PHACT™ S1000P Semi-Crystalline PHA (scPHA) today at NPE 2024 in Orlando, Florida.
- Woburn, Massachusetts--(Newsfile Corp. - May 8, 2024) - CJ Biomaterials, Inc, a division of South Korea-based CJ CheilJedang and a primary producer of polyhydroxyalkanoate (PHA) biopolymers, introduced PHACT™ S1000P Semi-Crystalline PHA (scPHA) today at NPE 2024 in Orlando, Florida.
- CJ Biomaterials entered the PHA market in 2022 when it introduced PHACT A1000P, its amorphous PHA (aPHA) solution.
- Compared to scPHA and crystalline PHA, aPHA is a softer, more rubbery version of the biopolymer that offers different performance characteristics.
- CJ Biomaterials introduced its newest polyhydroxyalkanoate (PHA) solution, PHACT™ S1000P Semi-Crystalline PHA , today at NPE 2024.